Welcome to LookChem.com Sign In|Join Free
  • or
Cyclohexanecarboxamide, 5-methyl-2-(1-methylethyl)-N-phenyl-, (1R,2S,5R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

824947-52-6

Post Buying Request

824947-52-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

824947-52-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 824947-52-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,4,9,4 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 824947-52:
(8*8)+(7*2)+(6*4)+(5*9)+(4*4)+(3*7)+(2*5)+(1*2)=196
196 % 10 = 6
So 824947-52-6 is a valid CAS Registry Number.

824947-52-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R)-3c-methyl-6t-isopropyl-cyclohexane-carbanilide-(1r)

1.2 Other means of identification

Product number -
Other names (1R,2S,5R)-2-Isopropyl-5-methyl-cyclohexanecarboxylic acid phenylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:824947-52-6 SDS

824947-52-6Downstream Products

824947-52-6Relevant academic research and scientific papers

TRP-P8 ACTIVE COMPOUNDS AND THERAPEUTIC TREATMENT METHODS

-

Page 51, (2008/06/13)

Compounds of the disclosure provide compositions, which are effective for prophylaxis and treatment of diseases or disorders, such as cell-proliferation, angiogenesis, or apoptosis mediated diseases. The disclosure encompasses compounds, analogs, prodrugs, metabolites, and pharmaceutically acceptable salts thereof, pharmaceutical compositions, and methods for prophylaxis and treatment of diseases and other maladies or conditions involving cancer, tumors, and like conditions. The disclosure also provides therapeutic methods including the administration of an effective amount of a compound of the disclosure.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 824947-52-6